Global Brain Positron Outflow Tomography Pet Magnetic Resonance Imaging Systems Market
Market Size in USD Billion
CAGR :
%

![]() |
2025 –2032 |
![]() |
USD 363.57 Million |
![]() |
USD 566.48 Million |
![]() |
|
![]() |
|
Global Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Segmentation, By Phase Type (Pre-Clinical and Clinical), Product (Helium-Free PET/MRI Systems and Traditional PET-MRI System), End User (Hospitals, Diagnostic Imaging Centres and Other End Users), – Industry Trends and Forecast to 2032
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Analysis
The brain positron emission tomography (PET)-magnetic resonance imaging (MRI) systems market is witnessing significant growth due to the increasing prevalence of neurological disorders, including Alzheimer’s disease and other dementias. These advanced imaging systems combine the functional imaging capabilities of PET with the structural imaging of MRI, enabling comprehensive assessments of brain activity and anatomy. Recent developments in this market focus on enhancing image resolution and acquisition speed, leading to more accurate diagnoses and treatment planning. Furthermore, the integration of artificial intelligence (AI) in image analysis is streamlining workflows and improving diagnostic accuracy. As healthcare providers increasingly adopt these hybrid systems for research and clinical applications, the market is poised for substantial expansion, driven by technological advancements and a growing emphasis on personalized medicine. This combination of factors underscores the pivotal role that PET-MRI systems play in advancing neuroimaging and improving patient outcomes in neurology.
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Size
The global brain positron outflow tomography (PET)-magnetic resonance imaging (MRI) systems market size was valued at USD 363.57 million in 2024 and is projected to reach USD 566.48 million by 2032, with a CAGR of 5.70% during the forecast period of 2025 to 2032. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Trends
“Advancements in Imaging Technology”
The Brain Positron Emission Tomography (PET)-Magnetic Resonance Imaging (MRI) systems market is evolving rapidly, driven by advancements in imaging technology and a growing focus on early diagnosis of neurological disorders. One notable trend is the increasing integration of artificial intelligence (AI) and machine learning algorithms, which enhance image analysis and interpretation, enabling clinicians to make more informed decisions. Recent innovations include the development of hybrid imaging systems that offer improved resolution and faster acquisition times, significantly enhancing the accuracy of diagnoses. Additionally, the introduction of portable and cost-effective PET-MRI systems is expanding access to advanced imaging capabilities in various healthcare settings. These innovations cater to a broader patient demographic and foster greater adoption among healthcare providers. As the demand for precise and comprehensive neuroimaging solutions continues to rise, the PET-MRI systems market is poised for significant growth, contributing to improved patient outcomes and advancing research in neurology.
Report Scope and Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Segmentation
Attributes |
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Key Market Insights |
Segments Covered |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Key Market Players |
Siemens (Germany), Koninklijke Philips N.V. (Netherlands), General Electric Company (U.S.), Bruker (U.S.), Mediso Ltd. (Hungary), MR Solutions (U.K.), Cubresa Inc. (Canada), Scintica Instrumentation, Inc. (Canada), CANON MEDICAL SYSTEMS CORPORATION (Japan), Carestream Health (U.S.), Esaote SPA (Italy), FONAR Corp. (U.S.), Hitachi Ltd. (Japan), inviscan SAS (France), Shanghai United Imaging Healthcare Co., Ltd. (China) |
Market Opportunities |
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. |
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Definition
Brain positron emission tomography (PET)-magnetic resonance imaging (MRI) systems are advanced hybrid imaging technologies that combine the functional imaging capabilities of PET with the detailed structural imaging of MRI. PET is a nuclear medicine technique that detects metabolic processes in the brain by using radioactive tracers, allowing for the visualization of brain activity and the identification of abnormalities such as tumors or neurological disorders. MRI, on the other hand, uses strong magnetic fields and radio waves to produce high-resolution images of brain anatomy, providing critical information about the structure and integrity of brain tissues. Together, these systems offer a comprehensive view of both the functional and structural aspects of the brain, enhancing diagnostic accuracy and aiding in the effective management of various neurological conditions. Their integration plays a crucial role in research, diagnostics, and treatment planning for a wide range of brain disorders.
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Dynamics
Drivers
- Increasing Prevalence of Neurological Disorders
The rising incidence of neurological disorders, such as epilepsy, Parkinson's disease, Alzheimer's disease, and brain tumors, is significantly driving the demand for PET-MRI systems. According to Alzheimer's disease International, approximately 55 million people were living with dementia in 2020, a figure projected to nearly double every two decades, reaching 78 million by 2030 and 139 million by 2050. Additionally, over 10 million individuals are affected by Parkinson's disease, and around 50 million people suffer from epilepsy. The annual incidence of brain tumors is also notable, with approximately 700,000 new cases reported in the United States alone. These statistics highlight the urgent need for advanced imaging technologies. PET-MRI systems offer detailed insights into brain structure and function, facilitating early detection and accurate diagnosis, which are critical for managing these complex conditions. As the prevalence of these disorders continues to rise, the demand for innovative PET-MRI systems is expected to grow correspondingly.
- Technological Advancement
Innovations in PET/MRI systems, particularly the introduction of helium-free models, are playing a pivotal role in advancing the market by addressing both cost and environmental concerns. Traditional PET systems rely on helium for cooling, which is both expensive and environmentally harmful. Helium-free PET/MRI systems eliminate this issue, enhancing their sustainability and cost-effectiveness. Furthermore, advancements in software and hardware technologies are bolstering the performance of these systems. Integration technologies are streamlining workflows and enhancing diagnostic accuracy, leading to more reliable and user-friendly imaging solutions. As a result, modern PET/MRI systems are gaining popularity due to their enhanced functionality, affordability, and commitment to environmental sustainability, driving overall market growth.
Opportunities
- Growing Demand for Telemedicine and Remote Diagnostic
The rise of telemedicine and remote diagnostic capabilities has led to a significant demand for advanced imaging systems that facilitate remote consultations and diagnostics. As healthcare systems increasingly adopt telemedicine to enhance access and efficiency, the need for imaging technologies that can seamlessly integrate into remote platforms has become essential. In this context, sophisticated PET-MRI systems that deliver high-resolution imaging and comprehensive brain assessments are crucial. These systems enable clinicians to collaborate with specialists virtually, access and analyze imaging data from remote locations, and conduct consultations without geographical constraints. As healthcare solutions transition towards more remote models, the development and implementation of advanced imaging technologies will be imperative for achieving accurate diagnoses and effective remote patient management, presenting a substantial opportunity for market growth.
- Development Of Helium-Free PET Systems
Innovations in PET-MRI systems, particularly the development of helium-free PET systems, are significantly enhancing sustainability and cost-effectiveness. Traditional PET systems depend on helium for cooling, which presents both environmental and economic challenges. Helium-free models eliminate these issues, making them more attractive to healthcare providers. Additionally, advancements in software and hardware technologies are optimizing imaging performance, resulting in improved diagnostic accuracy and efficiency. These enhancements boost the reliability of PET-MRI systems and support a more streamlined workflow for clinicians. As healthcare organizations increasingly prioritize sustainable and economically viable solutions, the growing demand for advanced PET-MRI systems presents a compelling market opportunity, fostering further innovation and adoption in clinical settings.
Restraints/Challenges
- High of Cost Advanced Imaging Technologies
The acquisition and installation of PET-MRI systems necessitate a substantial capital investment, presenting a significant barrier for smaller healthcare facilities and those in emerging markets. The cost of these advanced imaging technologies encompasses the purchase price and installation expenses, specialized infrastructure requirements, and ongoing maintenance costs. For smaller institutions operating on tight budgets, this financial burden can limit their ability to adopt such innovative systems, potentially widening the gap in healthcare quality between large and small facilities. Additionally, in emerging markets, the lack of funding and resources can further restrict access to these crucial diagnostic tools. Consequently, the high costs associated with PET-MRI systems may hinder widespread adoption and utilization in the healthcare sector.
- Technical Limitations in PET-MRI Systems
PET-MRI systems provide enhanced imaging capabilities, their applicability is not universal across all diagnostic scenarios, presenting a significant market restraint. Certain medical conditions may necessitate alternative imaging modalities, such as computed tomography (CT) or standalone MRI, due to their specific strengths in diagnosing particular ailments. For instance, CT scans are often preferred for acute trauma cases or detailed visualization of bone structures, while traditional MRI may be more suitable for soft tissue evaluation. These limitations can restrict the utilization of PET-MRI systems in certain clinical settings, as healthcare providers must choose the most appropriate imaging technology based on the patient’s needs. Consequently, the reliance on alternative modalities can hinder the broader adoption of PET-MRI systems in diverse healthcare applications.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Scope
The market is segmented on the basis of phase type, product, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Phase Type
- Pre-Clinical
- Clinical
Product
- Helium-Free PET/MRI Systems
- Traditional PET-MRI Systems
End User
- Hospitals
- Diagnostic Imaging Centres
- Other End Users
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Regional Analysis
The market is analysed and market size insights and trends are provided by country, phase type, product and end user.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Asia-Pacific region leads the brain positron emission tomography (PET)-magnetic resonance imaging (MRI) systems market, driven by the growing adoption of advanced diagnostic equipment in research institutions and universities. Additionally, the rising demand for innovative diagnostic systems across various countries in the region is expected to further accelerate market growth during the forecast period. This combination of factors positions Asia-Pacific as a key player in advancing PET-MRI technology.
North America is expected to experience substantial growth in the brain positron emission tomography (PET)-magnetic resonance imaging (MRI) systems market, primarily driven by the increasing prevalence of neurological disorders. The rising incidence of conditions such as Alzheimer's disease, stroke, traumatic brain injury, epilepsy, multiple sclerosis, and Parkinson's disease is anticipated to further fuel the demand for advanced imaging solutions. This upward trend in neurological cases underscores the necessity for innovative diagnostic technologies, positioning the region for significant market expansion in the coming years.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Share
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market Leaders Operating in the Market Are:
- Siemens (Germany)
- Koninklijke Philips N.V. (Netherlands)
- General Electric Company (U.S.)
- Bruker (U.S.)
- Mediso Ltd. (Hungary)
- MR Solutions (U.K.)
- Cubresa Inc. (Canada)
- Scintica Instrumentation, Inc. (Canada)
- CANON MEDICAL SYSTEMS CORPORATION (Japan)
- Carestream Health (U.S.)
- Esaote SPA (Italy)
- FONAR Corp. (U.S.)
- Hitachi Ltd. (Japan)
- inviscan SAS (France)
- Shanghai United Imaging Healthcare Co., Ltd. (China)
Latest Developments in Brain Positron Outflow Tomography (PET)-Magnetic Resonance Imaging (MRI) Systems Market
- In June 2023, GE Healthcare announced the upcoming launch of its Signa PET/MRI AIR technologies, designed to enhance imaging quality. The company plans to showcase these innovative advancements at the Society of Nuclear Medicine and Molecular Imaging's annual meeting, scheduled to take place in Canada. This unveiling underscores GE Healthcare's commitment to advancing imaging technology and improving diagnostic capabilities in the medical field
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.